You are here

  • Home
  • Archive
  • Volume 77, Issue 8
  • Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2)

Article metrics

Article menu

This article has a correction. Please see:

Download PDFPDF
Clinical and epidemiological research
Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2)

 

Online download statistics by month:

Online download statistics by month: April 2018 to March 2024

AbstractFullPdf
Apr 20181435201138
May 20182499411325
Jun 20181019166118
Jul 20182240362256
Aug 20181422299221
Sep 20181005226187
Oct 2018993191136
Nov 2018642127105
Dec 20184559370
Jan 2019674158132
Feb 2019639111115
Mar 20195277576
Apr 20193759688
May 20194067455
Jun 20195448496
Jul 20194479088
Aug 20195549596
Sep 20196419188
Oct 20196779783
Nov 20196018277
Dec 20195347055
Jan 20205268496
Feb 20205425972
Mar 20204756661
Apr 20204245166
May 20204696472
Jun 20206508682
Jul 20205356668
Aug 20204746352
Sep 20205848977
Oct 20204735958
Nov 20205256566
Dec 20205846458
Jan 20219286956
Feb 20217277585
Mar 20217346570
Apr 20215646350
May 20213376573
Jun 2021856549
Jul 2021614742
Aug 2021896051
Sep 2021857268
Oct 20214617673
Nov 202173213772
Dec 20215647763
Jan 20225415151
Feb 20225497960
Mar 20225607756
Apr 20226457350
May 20226506139
Jun 20225675945
Jul 20224826035
Aug 20224856346
Sep 20227748143
Oct 20224863523
Nov 20227136239
Dec 20224625439
Jan 20234855628
Feb 20235125929
Mar 20238548156
Apr 20235646842
May 20237147451
Jun 20237186241
Jul 202377415859
Aug 20236276439
Sep 20234976230
Oct 20235486339
Nov 20237727553
Dec 202310288446
Jan 202480210374
Feb 202477610358
Mar 202490110362
Total4744368565418